Citation Impact
Citing Papers
The DNA-damage response in human biology and disease
2009 StandoutNature
The Variability of Results Between Point-of-Care Testing Glucose Meters and the Central Laboratory Analyzer
2006
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
1996 Nature
Diabetic retinopathy
2010 Standout
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Immunological responses to oxidized LDL
2000
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
2003
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
1993 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Beyond Cholesterol
1989 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
How hyperglycemia promotes atherosclerosis: molecular mechanisms
2002
DNA damage, p53, apoptosis and vascular disease
2007
Severe Sepsis and Septic Shock
2013 Standout
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
1998
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy
1995
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
1996
BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.
1996
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
1995
Unraveling the cytotoxicity and metabolic pathways of binary natural deep eutectic solvent systems
2017
Emerging drugs for diabetic retinopathy
2008
Atherosclerosis — An Inflammatory Disease
1999 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Diabetes and advanced glycation endproducts
2002
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Advanced glycoxidation end products in commonly consumed foods
2004
The role of oxidized lipoproteins in atherogenesis
1996
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Atherosclerosis
2001 Standout
A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases
2010
Frailty in elderly people
2013 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
Physiological Influences on Off-Finger Glucose Testing
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver.
1981 StandoutNobel
Interactions of native and modified human low density lipoproteins with human skin fibroblasts
1978
Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins
1978
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1980 Standout
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
1999 StandoutScience
Lipoprotein receptors and cholesterol homeostasis
1983
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Human apolipoprotein E isoprotein subclasses are genetically determined.
1981
Molecular Coproscopy: Dung and Diet of the Extinct Ground Sloth Nothrotheriops shastensis
1998 StandoutScienceNobel
Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region
1987 StandoutNatureNobel
THE TROMSØHEART-STUDY
1977
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
1981
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins.
1984
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1
2012
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Inflammation and Atherosclerosis
2002 Standout
Mechanism of cholesterol efflux from cells
1980
Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity.
1980
Insulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
2005
Green and Sustainable Solvents in Chemical Processes
2018 Standout
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Activation of Receptor for Advanced Glycation End Products
1999
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
1977
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
1984 StandoutNobel
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase
1979
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
2002
Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction
2002
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Effect of Probucol Treatment on Gene Expression of VCAM-1, MCP-1, and M-CSF in the Aortic Wall of LDL Receptor–Deficient Rabbits During Early Atherogenesis
1997
Replacement of neutral lipids of low density lipoprotein with esters of long chain unsaturated fatty acids.
1979 StandoutNobel
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
1994
CHOLESTEROL METABOLISM IN MAN
1955
Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex
1995
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
1997
The biology of platelet-derived growth factor
1986 Standout
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
1981 StandoutNobel
Receptor-mediated uptake of low density lipoprotein reconstituted with 25-hydroxycholesteryl oleate suppresses 3-hydroxy-3-methylglutaryl-coenzyme A reductase and inhibits growth of human fibroblasts
1978 StandoutNobel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 StandoutNobel
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
1979
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Improved Insulin Sensitivity Is Associated With Restricted Intake of Dietary Glycoxidation Products in the db/db Mouse
2002
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
A molecular analysis of dietary diversity for three archaic Native Americans
2001 StandoutNobel
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
1980
Works of Theodor Koschinsky being referenced
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus
2007
Glucose Sensors and the Alternate Site Testing-Like Phenomenon: Relationship Between Rapid Blood Glucose Changes and Glucose Sensor Signals
2003
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
1993
Benfotiamine Prevents Macro- and Microvascular Endothelial Dysfunction and Oxidative Stress Following a Meal Rich in Advanced Glycation End Products in Individuals With Type 2 Diabetes
2006
A comparative study of surface binding of human low density and high density lipoproteins to human fibroblasts: regulation by sterols and susceptibility to proteolytic digestion
1977
Interaction between High Density and Low Density Lipoproteins during Uptake and Degradation by Cultured Human Fibroblasts
1977
A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESS
1976
Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits
1995
Glucose Monitoring at the Arm
2002